Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

JOSHUA OAKS

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1205221405
CMS profile
4223037
Location
BOUNTIFUL, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$2,511.56

180 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,411.57 179
Education $99.99 1

By paying entity

PY2021 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

JOSHUA OAKS

NPI 1205221405 · CMS profile ID 4223037

Allopathic & Osteopathic Physicians / Internal Medicine

BOUNTIFUL, UT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1205221405?year=2021&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
JOSHUA OAKS, NPI 1205221405, CMS profile ID 4223037. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1205221405?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). JOSHUA OAKS, NPI 1205221405, CMS profile ID 4223037. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1205221405?year=2021&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
JOSHUA OAKS, NPI 1205221405, CMS profile ID 4223037, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 180 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1205221405?year=2021&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

180 matching records · $2,511.56 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 180 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 180.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $12.9906/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829671323 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.4506/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763400862 CMS
Merck Sharp & Dohme Corporation $15.0006/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848485459 CMS
Amarin Pharma Inc. $14.7306/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815245045 CMS
AbbVie Inc. $23.2406/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795393081 CMS
PFIZER INC. $12.8206/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833456169 CMS
PFIZER INC. $2.7105/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832740537 CMS
Amarin Pharma Inc. $2.0705/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815383643 CMS
Novartis Pharmaceuticals Corporation $13.2605/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 813125993 CMS
Janssen Pharmaceuticals, Inc $16.4605/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787984607 CMS
SANOFI-AVENTIS U.S. LLC $12.6505/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843704951 CMS
Astellas Pharma US Inc $9.9305/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821474149 CMS
Amgen Inc. $16.7905/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825474133 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.2105/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763400864 CMS
E.R. Squibb & Sons, L.L.C. $19.3705/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783484245 CMS
AstraZeneca Pharmaceuticals LP $15.9605/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830095273 CMS
Horizon Therapeutics plc $11.5605/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 797180421 CMS
Novo Nordisk Inc $1.0305/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810714587 CMS
Novo Nordisk Inc $15.3305/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811658059 CMS
Amarin Pharma Inc. $3.6405/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815417705 CMS
Xeris Pharmaceuticals, Inc. $16.3705/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837437917 CMS
Amarin Pharma Inc. $5.1505/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815245043 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.9804/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763400866 CMS
Astellas Pharma US Inc $17.5204/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821474143 CMS
Nestle HealthCare Nutrition Inc. $21.1504/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820937093 CMS
SANOFI-AVENTIS U.S. LLC $13.1804/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843704939 CMS
Merck Sharp & Dohme Corporation $16.6704/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848712137 CMS
Novo Nordisk Inc $19.0404/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811532041 CMS
Kowa Pharmaceuticals America, Inc. $11.7504/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 805544281 CMS
ARBOR PHARMACEUTICALS, INC. $14.0704/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830938459 CMS
Amarin Pharma Inc. $6.8604/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815245041 CMS
PFIZER INC. $16.3004/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833402183 CMS
AstraZeneca Pharmaceuticals LP $15.8304/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830082169 CMS
Lilly USA, LLC $12.5904/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818619323 CMS
Astellas Pharma US Inc $99.9903/31/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821474137 CMS
DEXCOM, INC. $13.6903/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845291891 CMS
Amarin Pharma Inc. $12.2203/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815417687 CMS
Lilly USA, LLC $15.4303/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818616181 CMS
Amarin Pharma Inc. $2.3503/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815209759 CMS
SANOFI-AVENTIS U.S. LLC $14.0503/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843704927 CMS
AstraZeneca Pharmaceuticals LP $11.6203/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830086659 CMS
Janssen Pharmaceuticals, Inc $13.9603/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 787984609 CMS
Amgen Inc. $15.7803/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825474145 CMS
Merck Sharp & Dohme Corporation $19.2503/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848323499 CMS
Amarin Pharma Inc. $14.2003/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815245031 CMS
Amarin Pharma Inc. $4.3503/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815383639 CMS
AstraZeneca Pharmaceuticals LP $12.6903/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829408267 CMS
ARBOR PHARMACEUTICALS, INC. $15.3303/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830938437 CMS
Lilly USA, LLC $18.2503/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818580025 CMS
GlaxoSmithKline, LLC. $16.4103/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 803056475 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,902.12 159
PY2020 $2,140.77 143
PY2021 $2,511.56 180
PY2022 $2,381.25 154
PY2023 $2,357.94 148
PY2024 $2,844.14 151
PY2025 $2,300.85 147

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $144,881.18 8
PY2024 Principal investigator $82,256.34 2
PY2023 Recipient $50.00 1
PY2023 Principal investigator $223,046.27 20
PY2022 Recipient $50.00 1
PY2022 Principal investigator $192,951.78 17
PY2021 Principal investigator $102,343.68 2
PY2020 Principal investigator $210,615.99 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alnylam Pharmaceuticals Inc. $12,578.22 12/19/2025 Non-covered Recipient Entity
Progressive Clinical Research LLC
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508049
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,109.24 11/12/2025 Non-covered Recipient Entity
PROGRESSIVE CLINICAL RESEARCH
A multi-center, randomized, double-blind, placebo-controlled, parallel-group, dose-finding study to evaluate efficacy, safety, and tolerability of DII235 in adults with elevated lipoprotein(a) No dispute reported 06/30/2026 1190313029
Principal investigator 1 Alnylam Pharmaceuticals Inc. $8,500.00 11/05/2025 Non-covered Recipient Entity
Progressive Clinical Research LLC
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508054
Principal investigator 1 Alnylam Pharmaceuticals Inc. $3,377.00 11/05/2025 Non-covered Recipient Entity
Progressive Clinical Research LLC
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease No dispute reported 06/30/2026 1215508060
Principal investigator 1 Novartis Pharmaceuticals Corporation $18,920.18 08/04/2025 Non-covered Recipient Entity
PROGRESSIVE CLINICAL RESEARCH
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190309840
Principal investigator 1 Novartis Pharmaceuticals Corporation $44,472.29 07/15/2025 Non-covered Recipient Entity
PROGRESSIVE CLINICAL RESEARCH
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190309842
Principal investigator 1 Novartis Pharmaceuticals Corporation $22,103.34 01/15/2025 Non-covered Recipient Entity
PROGRESSIVE CLINICAL RESEARCH LLC
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease No dispute reported 06/30/2026 1190306589
Principal investigator 1 Novartis Pharmaceuticals Corporation $33,820.91 01/14/2025 Non-covered Recipient Entity
PROGRESSIVE CLINICAL RESEARCH LLC
Randomized, Double-blind, Placebo-controlled, Multicenter Trial, Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Participants With Established Cardiovascular Disease (VICTORION-2 PREVENT) No dispute reported 06/30/2026 1190306587